Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Sintilimab in Hepatocellular Carcinoma: NCT07352007 Clinical Landscape Report 2026
16 October 2026
NCT07352007 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Leiolizumab in Colitis, Ulcerative: NCT07350577 Clinical Landscape Report 2026
16 October 2026
NCT07350577 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Remimazolam Tosylate in Emergence Delirium: NCT07351474 Clinical Landscape Report 2026
16 October 2026
NCT07351474 clinical landscape for Emergence Delirium: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pucotenlimab in HER2 negative Gastric Cancer: NCT07356466 Clinical Landscape Report 2026
16 October 2026
NCT07356466 clinical landscape for HER2 negative Gastric Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Hypertension, Portal: NCT07350070 Clinical Landscape Report 2026
16 October 2026
NCT07350070 clinical landscape for Hypertension, Portal: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Megestrol Acetate in Locally Advanced Hepatocellular Carcinoma: NCT07356037 Clinical Landscape Report 2026
16 October 2026
NCT07356037 clinical landscape for Locally Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Axelopran in Lung Cancer: NCT07354919 Clinical Landscape Report 2026
16 October 2026
NCT07354919 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
3H-10000 in Lung Cancer: NCT07354711 Clinical Landscape Report 2026
16 October 2026
NCT07354711 clinical landscape for Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KNP 502 in Human epidermal growth factor 2 negative carcinoma of breast: NCT07358806 Clinical Landscape Report 2026
16 October 2026
NCT07358806 clinical landscape for Human epidermal growth factor 2 negative carcinoma of breast: endpoints, sponsor, phase, geography, readouts, asset contex…
9 min read
QLS5316 in Squamous Cell Carcinoma of Head and Neck: NCT07358884 Clinical Landscape Report 2026
16 October 2026
NCT07358884 clinical landscape for Squamous Cell Carcinoma of Head and Neck: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Nesuparib in Recurrent Metastatic Gastric Carcinoma: NCT07364422 Clinical Landscape Report 2026
16 October 2026
NCT07364422 clinical landscape for Recurrent Metastatic Gastric Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
CREPT-618 in Locally Advanced Hepatocellular Carcinoma: NCT07364357 Clinical Landscape Report 2026
16 October 2026
NCT07364357 clinical landscape for Locally Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…